Several studies have shown altered glycosylation patterns in AD patients, such as increased levels of bisecting GlcNAc, altered salivary acidification, decreased expression of salivary acid transferase (ST), and increased expression of the enzyme responsible for the conversion (GnT-III) [14, 115–118]. Here, MGAT3 is linked to Alzheimer disease.